Abstract:Implementation of effective cancer treatment strategies requires consideration of how the spatiotemporal heterogeneities within the tumor microenvironment (TME) influence tumor progression and treatment response. Here, we developed a multi-scale three-dimensional mathematical model of the TME to simulate tumor growth and angiogenesis and then employed the model to evaluate an array of single and combination therapy approaches. Treatments included maximum tolerated dose or metronomic (i.e., frequent low doses) scheduling of anti-cancer drugs combined with anti-angiogenic therapy. The results show that metronomic therapy normalizes the tumor vasculature to improve drug delivery, modulates cancer metabolism, decreases interstitial fluid pressure and decreases cancer cell invasion. Further, we find that combining an anti-cancer drug with anti-angiogenic treatment enhances tumor killing and reduces drug accumulation in normal tissues. We also show that combined anti-angiogenic and anti-cancer drugs can decrease cancer invasiveness and normalize the cancer metabolic microenvironment leading to reduced hypoxia and hypoglycemia. Our model simulations suggest that vessel normalization combined with metronomic cytotoxic therapy has beneficial effects by enhancing tumor killing and limiting normal tissue toxicity. Effective treatment of solid tumors with injected drugs requires that sufficient exposure of cancer cells to the cytotoxic drugs. However, non-uniform and poorly functioning blood vessels make this difficult. The amount of drug that reaches a given cancer cells depends on many factors, including the drug chemistry, its lifetime in the blood circulation, its ability to cross the blood vessel wall and enter the tissue, and the schedule of the injections. We present a mathematical model of tumor growth, angiogenesis, metabolism and drug transport that examines how these processes affect the response to treatment. We find that low dose, high frequency (metronomic) therapy normalizes the tumor vasculature to improve drug delivery and that combining an anti-cancer drug with a drug that specifically enhances vascular function increases tumor killing and reduces drug accumulation in normal tissues. Our model simulations suggest that vessel normalization combined with metronomic cytotoxic therapy has beneficial effects by enhancing tumor killing and limiting normal tissue toxicity.

3D numerical study of tumor microenvironmental flow in response to vascular-disrupting treatments.

Numerical Simulation of Hemodynamics in the Host Blood Vessel and Microvascular Network Generated from Tumor-Induced Angiogenesis

Study on Hypovascular Tumor' S Treatment with Targeted Mierobubbles Combined with Ultrasonic Abrupted Destroy

Research on the Effect of Microenvironment of Tumor Blood Perfusion under Anti-angiogenesis Therapy

Numerical simulation of blood flow and interstitial fluid pressure in solid tumor microcirculation based on tumor-induced angiogenesis

The influence of tumour vasculature on fluid flow in solid tumours: a mathematical modelling study

Biologically-Based Mathematical Modeling of Tumor Vasculature and Angiogenesis via Time-Resolved Imaging Data

Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization

Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation

Modeling three-dimensional invasive solid tumor growth in heterogeneous microenvironment under chemotherapy

Monitoring microvascular tortuosity and velocity distribution response of 4T1 tumor to the DOX-NDs treatment using super-resolution ultrasound imaging

Biochemomechanical Modeling of Vascular Collapse in Growing Tumors

Biomechanical modelling of tumor growth with chemotherapeutic treatment: A review

Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery

Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy.

Microfluidic Modulation of Microvasculature in Microdissected Tumors

Modeling of chemo-radiotherapy targeting growing vascular tumors: a continuum-level approach

Flow correlated percolation during vascular network formation in tumors

Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function

Quantifying 3D Tumor Microvascular Heterogeneity Via Super-resolution Ultrasound Imaging to Categorize and Characterize Microvascular Subgroups in U87 Glioblastoma

Flow-Induced Vascular Remodeling On-Chip: Implications for Anti-VEGF Therapy